Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-17
2007-04-17
Padmanabhan, Sreeni (Department: 1617)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S269700, C206S385000, C206S810000, C206S309000, C206S570000
Reexamination Certificate
active
10427607
ABSTRACT:
Novel solvates and crystal polymorphs of Ritonavir are disclosed, as well as methods of making them. Specific solvates of the compound include a formamide solvate and a partially desolvated solvate. Also disclosed are methods of making previously known forms of Ritonavir. Methods of using the novel forms of Ritonavir for the treatment of diseases, such as HIV-infection, are disclosed, as are pharmaceutical compositions and unit dosage forms comprising the novel forms of Ritonavir.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5541206 (1996-07-01), Kempf et al.
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5635523 (1997-06-01), Kempf et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5846987 (1998-12-01), Kempf et al.
patent: 5886036 (1999-03-01), Kempf et al.
patent: 6037157 (2000-03-01), Norbeck et al.
patent: 6232333 (2001-05-01), Lipari et al.
patent: 6284767 (2001-09-01), Sham et al.
patent: 6977723 (2005-12-01), Lemmo et al.
patent: 7061605 (2006-06-01), Lemmo et al.
patent: WO00/04016 (2000-01-01), None
patent: WO 00/04016 (2000-01-01), None
patent: WO01/51919 (2001-07-01), None
Bauer, J., et al., Pharm. Res., 18(6):859-866 (2001).
Chemburkar, S., et al., Organic Process Research and Development, 4:413-417 (2000).
Kumar, G.N., et al., Drug Metabolism and Disposition, 27(8):902-908 (1999).
Law, D., et al., Journal of Pharmaceutical Sciences, 90(8): 1015-1025 (2001).
Press Release, “Abbott Announces Difficulty Manufacturing Norvir® (ritonavir) Capsules”, Abbott Park, Illinois, Jul. 27, 1998.
Press Release, “Abbott Laboratories Submits New Drug Application to U.S. Food and Drug Administration for Reformulated Norvir® Capsules”, Abbott Park, Illinois, Mar. 31, 1999.
Press Release, “Abbott Laboratories Receives U.S. FDA Approval for Reformulated Norvir® (ritonavir) Capsule”, Abbott Park, Illinois, Jun. 30, 1999.
Press Release, “Abbott Laboratories Receives European Commission Marketing Authorization for Reformulated Norvir® (ritonavir) Capsules”, Abbott Park, Illinois, Dec. 1, 1999.
Press Release, “Studies of Norvir® (ritonavir) Combined with Other Protease Inhibitors Show Promise in HIV”, Abbott Park, Illinois, Feb. 3, 2000.
Almarsson Orn
Morissette Sherry L.
Soukasene Stephen
Burgess Paul
Carter Kendra D.
TransForm Pharmaceuticals, Inc.
LandOfFree
Solvates and polymorphs of ritonavir and methods of making... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solvates and polymorphs of ritonavir and methods of making..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solvates and polymorphs of ritonavir and methods of making... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780826